Pediatricians Who Serve Trans Youth Face Increasing Harassment. Lifesaving Care Could Be on the Line
Dr. Gina Sequeira first saw the protesters on a bright clear morning last September. A co-director of Seattle Children’s Gender Clinic who provides gender-affirming care to young people, Sequeira had confronted ignorance about her medical specialty in the past. But nothing had prepared her to see people outside her office, waving signs and handing out flyers warning of the “dangers” of the work she does.
“That was really, really hard for us as a clinic,” she says. “And I think it was really hard for the hospital’s patients and families who witnessed it.” Just a month later, p...
Source: TIME: Health - February 16, 2022 Category: Consumer Health News Authors: Madeleine Carlisle Tags: Uncategorized feature Health Care LGBTQ nationpod News Source Type: news
When Can Menstrual Suppression Start in Patients with a Disability?
Discussion
Menstrual suppression using hormonal therapy is commonly used for a variety of reasons:
Patient preference
Contraception
Heavy or painful menses
Treatment of concomitant problems such as menstrual migraine, mood issues, nausea
Specific patient populations
Disabilities
Oncology
Transgender and gender nonbinary
Methods of suppression include:
Estrogen and progesterone
Combined oral contraceptives (COC) – very good menstrual suppression and generally used as first line treatment for many patients
Traditional dosing with active medication for 21-24 days and then 4-7 day placebo break.
Extended cycles &...
Source: PediatricEducation.org - February 14, 2022 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
Updated Endometriosis Guidelines: Less Laparoscopy, More Hormone Therapy Updated Endometriosis Guidelines: Less Laparoscopy, More Hormone Therapy
Updated guidelines have been issued for the management and treatment of endometriosis.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 8, 2022 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news
Hormone therapy may shut off alcoholics' cravings for booze
University of Iowa researchers gave monkeys with a strong preference for alcohol a synthetic version of the hormone FGF21 for 16 days. It was shown to cut ethanol intake by 50%. (Source: the Mail online | Health)
Source: the Mail online | Health - February 1, 2022 Category: Consumer Health News Source Type: news
Prostate MRI predicts urinary continence after surgery
Measurements of the urethra seen on MRI exams prior to surgery may predict urinar...Read more on AuntMinnie.comRelated Reading:
When to biopsy: How prostate MRI can transform best practice
PET/MRI bests MRI alone for detecting recurrent prostate cancer
ASTRO: Is hormone therapy after prostate surgery needed?
Guidelines revised for rad therapy after prostatectomy (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 20, 2022 Category: Radiology Source Type: news
For Transgender People, Starting Hormone Therapy in Teens Helps Mental Health
(Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - January 14, 2022 Category: Psychiatry Tags: Endocrinology, Gynecology, Nursing, Pediatrics, Psychiatry, Reproductive Medicine, News, Source Type: news
Association of gender-affirming hormone therapy with depression, thoughts of suicide, and attempted suicide among transgender and nonbinary youth - Green AE, DeChants JP, Price MN, Davis CK.
PURPOSE: There are no large-scale studies examining mental health among transgender and nonbinary youth who receive gender-affirming hormone therapy (GAHT). The purpose of this study is to examine associations among access to GAHT with depression, thoughts... (Source: SafetyLit)
Source: SafetyLit - December 21, 2021 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
Gender-Affirming Hormone Therapy for LGBTQ Youth Can Help Save Lives, Study Finds
The use of gender-affirming hormone therapy (GAHT) is significantly related to lower rates of depression, suicidal ideation and suicide attempts among transgender and nonbinary youth, according to a study published in the Journal of Adolescent Health on Tuesday.
The peer-reviewed study comes from researchers at The Trevor Project, a nonprofit focused on suicide prevention among LGBTQ youth, and is the first large-scale study to examine GAHT’s impact on trans and nonbinary young people. The study examines data collected in a Trevor Project survey of over 34,000 LGBTQ youth between the ages of 13 and 24 across the U.S...
Source: TIME: Health - December 14, 2021 Category: Consumer Health News Authors: Madeleine Carlisle Tags: Uncategorized LGBTQ nationpod News Source Type: news
Irving-based hormone company CEO on advocating for more women ’s health research
Irving-based Biote is a hormone optimization company that offers patients personalized hormone therapy and clinical-grade nutraceuticals. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - November 30, 2021 Category: American Health Authors: Plamedie Ifasso Source Type: news
Hormone therapy could prevent thousands of miscarriages each year in Britain, new NHS guidance says
Britain's health watchdog has approved the drug progesterone for expectant mothers who have previously had a miscarriage and are experiencing spotting or bleeding. (Source: the Mail online | Health)
Source: the Mail online | Health - November 24, 2021 Category: Consumer Health News Source Type: news
Changing Cancer Care, So Patients No Longer Feel Like a Number
“Having cancer is terrifying. It’s scary. And going to the hospital—I really felt like a number,” says Marc Hulett, who was diagnosed with prostate cancer in 2004.
Hulett had surgery to remove his prostate and has been on hormone therapy for 17 years. Every three months, he gets a blood test to monitor his progress, but he no longer feels like a number. He drives from his home in Palm Springs, Calif., to Los Angeles—which can take up to six hours—to see his oncologist, Dr. David Agus, at the Ellison Institute for Transformative Medicine.
As the name suggests, the Institute isn’t ju...
Source: TIME: Health - November 3, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Cancer healthscienceclimate Source Type: news
Mayo Clinic Q & amp;A podcast: Systemic therapies for breast cancer
Systemic therapies are drugs that are taken orally or by IV to treat cancer. Types of systemic therapies for breast cancer include chemotherapy, hormone therapy, immunotherapy and targeted drug therapy. Which therapy is used depends on which type of breast cancer is being treated. "The goal of systemic therapy is simply to either inhibit the growth of cancer cells or to kill them and to eradicate them from the body," says Dr. Matthew Goetz, a… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - October 18, 2021 Category: Databases & Libraries Source Type: news
New Nonhormonal Therapies for Hot Flashes on the Horizon New Nonhormonal Therapies for Hot Flashes on the Horizon
Various therapies could become options women with contraindications for hormone therapy, such as a history of breast cancer or coronary heart disease.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 8, 2021 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news
Prostate cancer drugs that halve risk of dying: New hope for patients thanks to new treatment
Around 10,000 men a year in the UK have an aggressive form of prostate cancer, which is treated with hormone therapy and radiotherapy. A new drug could halve death rates over six years. (Source: the Mail online | Health)
Source: the Mail online | Health - September 20, 2021 Category: Consumer Health News Source Type: news
‘Highly effective’ ovarian cancer treatment could help thousands of women
New drug combination shrunk tumours significantly in 46% of patients with treatment-resistant form of diseaseThousands of women withovarian cancer could benefit from a revolutionary drug combination after it was shown to shrink tumours in half of patients with an advanced form of the disease.The pair of drugs – which work together to block the signals cancer cells need to grow – could offer a new treatment option for women with a type of ovarian cancer that rarely responds to chemotherapy or hormone therapy.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - September 19, 2021 Category: Science Authors: Andrew Gregory Health editor Tags: Ovarian cancer Breast cancer Medical research Health Society Science Source Type: news
